Hearing · house
Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule
2024-03-21 · 14:00
Source status: Scheduled
Committee
Location
2123, Rayburn House Office Building
Video
Witnesses
Mr. Zach Rothstein, JD
Executive Director
Dr. Jeff Allen, PhD
President and CEO
Ms. Susan Van Meter
President
Dr. Dara L. Aisner, MD, PhD
Medical Director, Colorado Molecular Correlates Laboratory
Dr. Donald S. Karcher, MD, FCAP
President
Documents
Witness documents
- Witness Truth in Testimony · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
Hearing record
Committee activity
- The Honorable Frank Pallone, Jr. Opening Statement · Member Statements · PDF
- Documents For the Record · Support Document · PDF
- Hearing Notice · Support Document · PDF
- Public Memo · Support Document · PDF
- The Honorable Brett Guthrie Opening Statement · Member Statements · PDF
- The Honorable Cathy McMorris Rodgers Opening Statement · Member Statements · PDF
- The Honorable Anna Eshoo Opening Statement · Member Statements · PDF
Source: https://api.congress.gov/v3/committee-meeting/118/house/117011